Here are three stocks with buy rank and strong value characteristics for investors to consider today, December 2:
Embecta Corp. EMBC: This medical device company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 14.9% over the last 60 days.
Embecta Corp. price-consensus-chart | Embecta Corp. Quote
Embecta has a price-to-earnings ratio (P/E) of 7.97 compared with 25.13 for the S&P. The company possesses a Value Scoreof A.
Embecta Corp. pe-ratio-ttm | Embecta Corp. Quote
Blue Bird Corporation BLBD: This school bus manufacturer carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.9% over the last 60 days.
Blue Bird Corporation price-consensus-chart | Blue Bird Corporation Quote
Blue Bird Corporation has a price-to-earnings ratio (P/E) of 10.48 compared with 14.50 for the industry. The company possesses a Value Score of A.
Blue Bird Corporation pe-ratio-ttm | Blue Bird Corporation Quote
Enova International, Inc. ENVA: This technology and analytics company carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.1% over the last 60 days.
Enova International, Inc. price-consensus-chart | Enova International, Inc. Quote
Enova International has a price-to-earnings ratio (P/E) of 11.85 compared with 14.90 for the industry. The company possesses a Value Score of A.
Enova International, Inc. pe-ratio-ttm | Enova International, Inc. Quote
See the full list of top ranked stocks here.
Learn more about the Value score and how it is calculated here.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Enova International, Inc. (ENVA) : Free Stock Analysis Report
Blue Bird Corporation (BLBD) : Free Stock Analysis Report
Embecta Corp. (EMBC) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。
沒有相關數據
如果下載按鈕點擊無跳轉,請點擊右上角菜單選擇 “在瀏覽器打開”